GlassScriptPhysician profile
John J Sobuto
NPI 1033452883
$7,024.74
in general payments reported to CMS, 2019-2025
19 companies · $4,467 in 2025
The $4,467 reported for 2025 was more than what 92% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $35.82 · 2021: $115 · 2022: $153 · 2023: $229 · 2024: $1,573 · 2025: $4,467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,535 · Education: $2,500 · Food and Beverage: $1,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,534.89 |
| Education | $2,500.00 |
| Food and Beverage | $1,234.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,394.89 | 2022-2025 | |
| Medtronic, INC. | $1,308.35 | 2024 | Illumisite |
| Boehringer Ingelheim Pharmaceuticals, INC. | $491.76 | 2019-2024 | Ofev |
| Astrazeneca Pharmaceuticals LP | $133.34 | 2020-2021 | |
| Glaxosmithkline, LLC. | $127.52 | 2019-2025 | Trelegy Ellipta |
| Verona Pharma, INC. | $91.41 | 2025 | Ohtuvayre |
| Celgene Corporation | $90.32 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $87.98 | 2023-2024 | Opsumit |
| Genentech USA, INC. | $51.02 | 2023-2024 | Xolair |
| Mylan Specialty L.P. | $37.06 | 2019 | |
| Genzyme Corporation | $36.57 | 2019-2023 | |
| Grifols USA, LLC | $28.09 | 2025 | Prolastin-C Liquid |
| Mauna Kea Technologies, INC. | $28.05 | 2019 | |
| Baxter Healthcare | $24.23 | 2022 | |
| Insmed, INC. | $22.45 | 2025 | Brinsupri, Arikayce |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.40 | 2025 | Tezspire |
| Novartis Pharmaceuticals Corporation | $17.29 | 2020 | |
| Philips North America LLC | $17.14 | 2024 | (Ak6) Vest Therapy |
| Circassia INC. | $14.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sobuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.